Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REViVE Study of ambroxol hydrochloride with or without exercise in older adults
jRCTs031250498Completed
- Sponsor
- ASAGI Labs
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of ambroxol (4 arms), sponsored by ASAGI Labs. Primary endpoint: Change in 6-minute walk distance. Started Nov 2025; status: completed.
02
Drugs
ambroxol
Beyond the preview
Go deeper on jRCTs031250498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250498.